Edaravone Improves the Post-traumatic Brain Injury Dysfunction in Learning and Memory by Modulating Nrf2/ARE Signal...

Area of Science:

• Neuroscience
• Molecular Biology
• Pharmacology

Background:

• Traumatic brain injury (TBI) often leads to cognitive deficits.
• Oxidative stress plays a critical role in TBI-induced neuronal damage.
• Current treatments for TBI-related cognitive dysfunction are limited.

Purpose of the Study:

• To elucidate the molecular mechanisms of edaravone (EDA) in mitigating TBI-induced learning and memory impairments.
• To investigate EDA's effects on neuronal stem cells (NSCs) and brain tissue following injury.

Main Methods:

• Established in vitro (H2O2-treated NSCs) and in vivo (TBI rat) models.
• Assessed NSC activity, proliferation, and apoptosis using WST 1, MTT, and flow cytometry.
• Measured oxidative stress markers (MDA, LDH, ROS) and analyzed Nrf2/ARE pathway activation.

Main Results:

• EDA pretreatment enhanced NSC resistance to oxidative stress, increasing activity and proliferation while reducing apoptosis.
• EDA significantly decreased MDA, LDH, and ROS levels in NSCs.
• In TBI rats, EDA reduced brain trauma area, hippocampal injury, and improved learning/memory, accompanied by Nrf2/ARE pathway upregulation.

Conclusions:

• Edaravone (EDA) demonstrates neuroprotective effects against TBI.
• EDA functions by modulating the Nrf2/ARE signaling pathway, thereby improving NSC viability and cognitive function recovery.